**Author details**

Marcelo González\* and José Carlos Rivas Laboratorio de Investigación Materno Fetal (LIMaF), Departamento de Obstetricia y Ginecología, Facultad de Medicina, Universidad de Concepción, Concepción, Chile

\*Address all correspondence to: mgonzalezo@udec.cl

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**57**

*L-Arginine/Nitric Oxide Pathway and KCa Channels in Endothelial Cells: A Mini-Review*

[10] De Meyer GR, Herman AG. Vascular endothelial dysfunction. Progress in Cardiovascular Diseases.

[11] Kurowska EM. Nitric oxide therapies in vascular diseases. Current Pharmaceutical Design.

[12] Yang Z, Kaye DM. Endothelial dysfunction and impaired L-arginine transport in hypertension and

[13] González M. Regulation of expression and activity of l-arginine transporters by nutrients and hormones: A focus in transcriptional mechanisms regulated by glucose and insulin. En: Patel VB, Preedy VR, Rajendram R, editores. L-Arginine in Clinical Nutrition (Nutrition and Health). Cham: Springer International Publishing; 2017. pp. 71-83. DOI: 10.1007/978-3-319-26009-9\_6 [Accessed: 12 July 2020]

[14] Kalinowski L, Malinski T.

2004;**51**(2):459-469

2007;**39**(1):44-84

Endothelial NADH/NADPH-dependent enzymatic sources of superoxide production: Relationship to endothelial dysfunction. Acta Biochimica Polonica.

[15] Förstermann U. Oxidative stress in vascular disease: Causes, defense mechanisms and potential therapies. Nature Clinical Practice. Cardiovascular

[16] Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. The International Journal of Biochemistry & Cell Biology.

Medicine. 2008;**5**(6):338-349

genetically predisposed normotensive subjects. Trends in Cardiovascular Medicine. 2006;**16**(4):118-124

1997;**39**(4):325-342

2002;**8**(3):155-166

*DOI: http://dx.doi.org/10.5772/intechopen.93400*

[1] Augustin HG, Kozian DH, Johnson RC. Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes. BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology.

[2] Fishman AP. Endothelium: A

distributed organ of diverse capabilities. Annals of the New York Academy of

[3] Galley HF, Webster NR. Physiology of the endothelium. British Journal of Anaesthesia. 2004;**93**(1):105-113

[4] Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature.

1994;**16**(12):901-906

Sciences. 1982;**401**:1-8

1980;**288**(5789):373-376

1984;**308**(5960):645-647

1988;**12**(4):365-372

2004;**15**(8):1983-1992

2008;**60**(1):139-143

[5] Griffith TM, Edwards DH,

Lewis MJ, Newby AC, Henderson AH. The nature of endothelium-derived vascular relaxant factor. Nature.

[6] Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endotheliumderived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences of the United States of America. 1987;**84**(24):9265-9269

[7] Moncada S, Palmer RM, Higgs EA. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension (Dallas, Tex.: 1979).

[8] Endemann DH, Schiffrin EL. Endothelial dysfunction. Journal of the American Society of Nephrology: JASN.

[9] Aird WC. Endothelium in health and disease. Pharmacological Reports.

**References**

*L-Arginine/Nitric Oxide Pathway and KCa Channels in Endothelial Cells: A Mini-Review DOI: http://dx.doi.org/10.5772/intechopen.93400*
